Prostate-Specific Antigen: From Promising to Disappointment Tool for Diagnosis of Chronic Renal Failure in Predialysis Patients

Prostate-Specific Antigen: From Promising to Disappointment Tool for Diagnosis of Chronic Renal Failure in Predialysis Patients

Introduction Prostate-specific antigen (PSA) is a biomarker commonly used for detection of prostate cancer. Its viability as a marker for diagnosis of chronic renal failure (CRF) in predialysis patients was investigated. Methods Sera from 230 patients with CRF were analyzed by enzyme-linked immunos...

Full description

Bibliographic Details
Main Author:	Ali Abdul Hussein S Al-Janabi
Format:	Article
Language:	English
Published:	Thieme Medical Publishers, Inc. 2021-04-01
Series:	Asian Journal of Oncology
Subjects:	psa chronic kidney failure prostate renal dialysis
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1729346

Similar Items

The Prevalence of Prostatic Cancer after Renal Transplantation
by: Mohammad Yazdani, et al.
Published: (2011-03-01)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01)

Prostate Specific Antigen Levels Among Men With Prostate Cancer in Ramadi City
by: Jalil Ibrahim Salih, et al.
Published: (2013-08-01)

The Accuracy of Increased Blood Concentration of Prostate-Specific Antigen to Prostate Malignancy
by: Daniel Mahendra Krisna, et al.
Published: (2018-04-01)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-03-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-08-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-09-01)

Assessment of pain in chronic renal failure patients going through hemodialysis
by: Fabiana Larissa Barbosa da Silva, et al.
Published: (2020-06-01)

Prostate Specific Antigen. Current clinical application and future prospects
by: Katerina Duskova, et al.
Published: (2015-03-01)

Evaluation of lipid parameters and bioindices in patients with different stages of chronic renal failure
by: Čabarkapa Velibor, et al.
Published: (2012-01-01)

Evaluation of the Cure about the Prostate Cancer Patients, Taking Radiothraphy According To the Result of the Prosecution Prostate Specific Antigen
by: Feryal Karaca, et al.
Published: (2018-10-01)

Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2005-01-01)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
by: Govinda Nanjaiah Laxmana Raju, et al.
Published: (2023-06-01)

Ciprofloxacin-Induced Renal Failure
by: Audra Fuller
Published: (2015-10-01)

Peritoneal dialysis in acute renal failure in canines: A review
by: R. H. Bhatt, et al.
Published: (2011-01-01)

Effect of urinary retention on the levels of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostatic disease
by: R Chawla, et al.
Published: (2003-01-01)

Investigation of prostate specific antigen glycosylation
by: Marinović Vesna, et al.
Published: (2000-01-01)

Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD
by: Ankur A. Dashputre, et al.
Published: (2021-02-01)

Comparison of changes in serum prostate specific antigen in prostate cancer patients treated either with flutamide or stilboestrol monotherapy
by: O F Otobo, et al.
Published: (2020-01-01)

Association between preoperative prostate-specific antigen levels and mortality in high- and intermediate-grade prostate cancer patients who received radical prostatectomy: Findings from the SEER database
by: Joshua Ikuemonisan, et al.
Published: (2021-06-01)

Cigarette smoking: an important renal risk factor – far beyond carcinogenesis
by: SR Orth
Published: (2003-06-01)

Evaluation of prostate-specific antigen testing: An empirical survey of laboratories in Nigerian tertiary care centers
by: Ijeoma A Meka, et al.
Published: (2022-01-01)

Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer
by: Marcin Miszczyk, et al.
Published: (2022-02-01)

Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making
by: Nnabugwu II, et al.
Published: (2014-12-01)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01)

Application and optimization of prostate-specific antigen screening strategy in the diagnosis of prostate cancer: a systematic review
by: Zhengchao Zhang, et al.
Published: (2024-01-01)

Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?
by: Shaan Kataria, et al.
Published: (2017-07-01)

Cancer incidence according to the National Health Information Database in Korean patients with end-stage renal disease receiving hemodialysis
by: Jisun Myung, et al.
Published: (2020-09-01)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
by: Ebenezer Abotsi, et al.
Published: (2022-12-01)

Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
by: Vilberg Jóhannesson, et al.
Published: (2021-04-01)

Review of commercially available biomarkers in the diagnosis of prostate cancer
by: Magdalena Ostrowska, et al.
Published: (2022-11-01)

Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”
by: Simon Robinson, et al.

Nanobodies: a tool to open new horizons in diagnosis and treatment of prostate cancer
by: Maryam Hosseindokht, et al.
Published: (2021-10-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate
by: Yung-Ting Cheng, et al.
Published: (2022-07-01)

Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy
by: Kevin Martell, et al.
Published: (2017-04-01)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
by: Jeong Hoon Phak, et al.
Published: (2016-03-01)

Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
by: Takuya Aizawa, et al.
Published: (2023-10-01)

Investigation of the Interobserver Variability of the Prostate Imaging for Recurrence Reporting (PI-RR) Score in Evaluating Local Recurrence in Prostate Cancer After Radiotherapy: Are Tumor Size and Prostate-specific Antigen Important?
by: Hüseyin Akkaya, et al.
Published: (2023-04-01)

ORAL CHANGES IN PATIENTS WITH CHRONIC RENAL FAILURE
by: Belazelkovska A., et al.
Published: (2013-07-01)